Reviews to Results: How Inspire TMS Tracks Patient Outcomes

Sam Clinch • February 17, 2026

Patients tell us the same thing again and again in reviews: they want clear evidence that treatment is working. At Inspire TMS Denver, we take that request literally - we don’t rely on impressions alone. We measure, record, and act on standardized outcome scores (like the PHQ-9) so every treatment decision is informed by data. That’s why our clinic reviews - the patient stories and high ratings you see online - are paired with hard numbers in our records: we translate “I feel better” into measurable change, and we use those numbers to shape treatment, follow-up, and long-term care. 


Why measurement matters


TMS is powerful because it changes brain circuits. But brain change doesn’t always track neatly with how someone says they feel, especially early in treatment. Standardized scales give clinicians a consistent, sensitive way to detect meaningful clinical change, monitor safety, and decide whether to continue, adjust, or remap a course.


At Inspire, we routinely use validated tools (most commonly the PHQ-9  for depression, and condition-specific measures where appropriate) before treatment, during the course, and at follow-up. These measures let us answer the crucial questions:


  • Is the patient improving, and by how much?


  • Is the current protocol producing the expected signal?


  • Do we need to remap, change pacing, or offer a maintenance/rescue plan?


Collecting and reviewing scores is not paperwork - it is how we turn patient experience into reproducible clinical decisions.


What your scores actually mean (PHQ-9 primer)


A few PHQ-9 facts are useful for patients:


  • PHQ-9 range: 0–27. Lower is better.


  • Common interpretive bands: 0–4 (minimal), 5–9 (mild), 10–14 (moderate), 15–19 (moderately severe), 20–27 (severe).


  • Clinical response is often defined as a ≥50% reduction in PHQ-9 score from baseline; remission is typically a score in the minimal or near-minimal range.
    These guidelines let clinicians quantify improvement and compare progress across visits.
    Research and clinic reports commonly show robust response and remission rates when TMS is delivered to completion - published and clinic-level data often cite response rates in the 60–75% range and remission rates approaching ~45–51% among full-course completers. Those benchmarks help us set realistic expectations and evaluate our own results.



How Inspire uses scores day-to-day



Here’s how outcome tracking informs care at Inspire:


Baseline & goals. We collect a baseline PHQ-9 (and other relevant scales). Dr. Clinch and the team set realistic targets and timelines — e.g., a 50% score reduction by week 4–6 — and share those with the patient.


Frequent measurement. We repeat scores at scheduled intervals during treatment (weekly or at clinically meaningful points) so we can detect early signals that predict longer-term response.


Data-driven adjustments. If scores plateau or worsen, we don’t guess - we review: does mapping need refinement? Is a medication interaction or a sleep problem present? Should we change protocol pacing, remap, or consider a rescue/maintenance plan? Remapping or protocol changes are common, evidence-driven steps when the data suggest they’re needed. 


Shared results & transparency. We show patients their numbers over time so they can see the progress (or lack of it) and participate in decisions. This transparency is part of why many patients report a better experience at Inspire - they understand how clinical choices are made and why.



Outcome scores and patient reviews - how they match up


Patient reviews are invaluable: they capture nuance, meaning, and quality of experience. But reviews are subjective and influenced by many non-clinical factors (appointment flow, staff warmth, travel ease). Outcome tracking gives a reproducible, objective counterpart.


At Inspire, we regularly compare patient-reported outcomes with review themes. When a patient posts a high-rating review that mentions life improvements, we can show the corresponding PHQ-9 change in the record. Conversely, when review feedback suggests a problem (e.g., persistent symptoms or side effects), our scores often highlight the clinical trajectory that underlies that feedback. This two-way verification - reviews and scores - helps us continuously improve care and confirms that good experience usually follows measurable clinical benefit.


Download Your Roadmap to TMS


Want a clear picture of what to expect? Download the TMS Treatment Roadmap by Sydney


Examples


  • Patient A: Baseline PHQ-9 20 → week 4 PHQ-9 9 (≥50% reduction). Patient reported “night-and-day” difference in mood and resumed work activities. This objective drop matched the glowing review they later posted.


  • Patient B: Baseline PHQ-9 17 → week 3 PHQ-9 15 (minimal change). We remapped and adjusted pacing; by week 6, PHQ-9 was 8, and the patient reported marked functional gains.


Fast clinical measurement → informed adjustment → better results. Remapping and protocol tweaks are not failures - they’re precision medicine in action.


Beyond PHQ-9 - broader outcome tracking


While PHQ-9 is central for depression, we also track condition-specific scales (GAD-7 for anxiety, OCD scales when relevant), functional measures (work/school participation), and patient satisfaction. All of these feed into a single clinical dashboard that Dr. Clinch reviews - it gives a 360° view of how the patient is doing and what’s needed next. Standardized tracking also enables Inspire to report clinic-level outcomes and refine protocols over time. 


What does measurement mean for you as a patient?



  • You’ll know early whether treatment is working. Objective scores detect change sooner than impressions alone.


  • Your care will be responsive. If numbers don’t improve, the team won’t wait - they’ll remap, re-dose, or change protocol.


  • How often will I take the PHQ-9?

    Typically at baseline, weekly during treatment blocks, at end of course, and during follow-up. Frequency may be adjusted to the clinical plan.

  • What counts as a “response” or “remission”?

    A common clinical standard is ≥50% reduction from baseline for response; remission is often defined as a PHQ-9 in the minimal range (e.g., ≤4). These thresholds guide clinical decisions.

  • What if my scores don’t improve?

    We review mapping, medications, sleep, and adherence; we may remap, adjust pacing/intensity, or consider maintenance/rescue strategies. Remapping and protocol adjustments are routine and evidence-based.

Every Question Answered

Want to know more about TMS? Check out this in-depth guide to TMS therapy with transparent and easy to understand explanations about TMS processes, protocols, and treated conditions.

Latest Posts

Pregnant woman preparing a salad in a bright kitchen by the window
By Sam Clinch • October 30, 2026
Depression during pregnancy is common and serious, and for mothers who want to avoid exposing their baby to medication, TMS is worth knowing about. It's a no...
Assorted medicine blister packs with pills on a newspaper-covered surface
By Sam Clinch • October 30, 2026
If you've tried two or more antidepressants without lasting relief, you're not out of options, you've reached the point where it's worth looking beyond anoth...
Two people in a bright office meeting, one taking notes while the other speaks on a sofa.
By Sam Clinch • October 30, 2026
Anxious depression is depression that comes with significant anxiety, the racing mind, the restlessness, the dread, on top of the low mood. It's common, it t...
Woman in blue scrubs standing in front of an Inspire TMS Denver sign.
By Sam Clinch • September 17, 2026
Stopped antidepressants because of the side effects? TMS avoids the systemic effects, weight gain, low libido, numbness, that make medication hard to tolerate.
Clinician adjusting a head-mounted device on a seated patient in a bright medical office
By Sam Clinch • September 17, 2026
Tried two or more antidepressants without relief? TMS is FDA-cleared for exactly that. An honest look at how it works when medication hasn't, and who it's for.
Five healthcare staff in blue scrubs standing together in a clinic hallway, smiling at the camera
By Sam Clinch • September 15, 2026
Does TMS cause weight gain? No. It's weight-neutral, unlike many antidepressants. Here's the honest reason why, and what any weight change during treatment means.
Clinician in blue scrubs adjusts a scalp treatment device on a smiling patient in a clinic chair
By Sam Clinch • September 15, 2026
Does TMS affect memory? No, it's not linked to lasting memory loss, and it isn't ECT. Here's the honest picture, including why your focus may actually improve.
Four healthcare staff in blue scrubs standing together in a clinic hallway, smiling at the camera.
By Sam Clinch • September 15, 2026
Is TMS safe? A straight look at the real side effects, the rare serious risks, and the truth behind "TMS ruined my life" stories, so you can decide clearly.
By Sam Clinch • August 25, 2026
Quick Answer: Yes. TriCare covers TMS for adults with major depressive disorder on an outpatient basis. TriCare is accepted at Inspire TMS Denver, and your benefits are checked before treatment begins so you know your costs up front. TMS is FDA-cleared for depression, and if antidepressants have not worked, it may be a covered next step. Depression is common in the military community, and it often travels alongside the other things service members and their families carry, including PTSD and anxiety. If medication has not brought the relief you were hoping for, TMS is worth understanding, and for TriCare beneficiaries it is a covered option. What Is TMS Therapy? TMS (transcranial magnetic stimulation) is a non-invasive, FDA-cleared treatment for depression. It uses targeted magnetic pulses to stimulate the areas of the brain involved in mood regulation. There is no anesthesia and no sedation. Most people drive themselves to and from sessions and go straight back to their day. It is usually considered when antidepressant medications have not provided enough relief, which is also the point at which TriCare coverage becomes relevant. Does TriCare Cover TMS? Yes, for major depressive disorder . TriCare covers TMS as an outpatient treatment for adults with major depressive disorder. TriCare is accepted at Inspire TMS Denver. Coverage still depends on your specific plan and on the documentation your provider submits, so it is not something to guess at. Rather than have you work it out alone, the clinic verifies your benefits before treatment begins and gives you an estimate of any out-of-pocket cost, so there are no surprises once you start. PTSD, Depression, and What TriCare Actually Covers This is the part worth being straight about, because it affects whether your treatment gets approved. TMS is FDA-cleared and TriCare-covered for major depressive disorder. It is not covered as a standalone treatment for PTSD. A lot of people in the military community come in thinking of PTSD as the main issue, and depression is very often part of that same picture. Where major depressive disorder is present and documented, that is the diagnosis that opens the door to TMS coverage. You do not need to untangle this yourself. During your evaluation, the clinical team determines the correct primary diagnosis and handles the paperwork that goes to TriCare. What helps most is being open about your full history, including your mood, your medication trials, and what has and has not worked. Who Does TriCare Cover? TriCare serves active duty service members, activated National Guard and Reserve members, military retirees, and their families. If you are a veteran who separated without retiring, your coverage may run through the VA rather than TriCare, which is a different pathway. If you are not sure which applies to you, the screening call is the fastest way to find out where you stand.
Dental clinician examining a seated patient in a bright clinic with panoramic windows.
By Sam Clinch • August 12, 2026
Quick Answer: As of August 2025, TMS is FDA-cleared for adolescents aged 15 to 21 with major depressive disorder, as an add-on (adjunct) to antidepressant medication for teens who haven't responded adequately to medication alone. It's non-invasive, drug-free, and done without sedation. It is not a replacement for medication or therapy, and at our clinic, a teen must have an existing psychiatrist and therapist to begin. This post explains what the clearance actually covers, what treatment involves, and how to tell if it's worth exploring for your child. If your teenager has been struggling with depression and medication hasn't been enough, you've probably reached the point of asking what else exists. TMS is now a real, FDA-cleared option for adolescents, but there's a lot of loose language online about what it is and who it's for. Here's the accurate version, written for parents who want the facts without the hype. Is TMS FDA-Cleared for Teenagers? Yes, with specific limits worth understanding. In August 2025, the FDA cleared the MagVenture TMS system , the equipment we use, as an adjunct treatment for major depressive disorder in adolescent patients aged 15 to 21. (Other manufacturers received similar adolescent clearances around the same period.) Two details matter here, because a lot of websites blur them: It's FDA-cleared, not "FDA-approved." Those are different regulatory pathways, and cleared is the correct term for TMS devices. The clearance covers ages 15 to 21, not an open-ended "15 and up." There's a defined upper bound. We're precise about this because when the topic is treating a minor, the details are the whole point. What "Adjunct" Actually Means This is the part most worth understanding. The FDA cleared TMS for adolescents as an adjunct, which means an add-on used alongside antidepressant medication, for teens who have not responded adequately to that medication on its own. It is not cleared as a replacement for medication, and the evidence in adolescents is strongest when TMS is added to an existing antidepressant rather than used by itself. So the honest framing is this: TMS is a way to boost the effect of treatment your teen is already on when that treatment hasn't been enough, not a way to take them off their medication. Any clinic suggesting TMS can simply replace a teenager's antidepressant is getting ahead of what the science and the clearance actually support. How TMS Works and What Treatment Involves TMS uses targeted magnetic pulses to stimulate a region of the brain involved in mood regulation, the left dorsolateral prefrontal cortex. It's non-invasive: nothing enters the body, there's no sedation or anesthetic, and your teen is fully awake throughout. Practically, for your child that means: Short daily sessions. Treatment sessions run about 18.5 minutes, with patients typically in and out of the office within half an hour. A weekday schedule. A standard course runs daily on weekdays over about six weeks, followed by a short taper of two to three weeks. No downtime. Because there's no sedation, teens can return to school and normal activities immediately after each session. Generally mild side effects. When they occur, side effects are usually localized: some scalp discomfort at the treatment site during the pulses, which typically stops as soon as the session ends, and occasional headaches that usually respond to over-the-counter pain relief. Often there are no side effects at all. TMS does not involve the sedation or systemic medication effects that come with some other treatments, and it is not associated with effects on memory or concentration. Why Consider TMS for a Teen? Adolescence is a period when depression often appears for the first time, and standard treatments don't always work. Some teens don't respond to the medications they try; others struggle with side effects or find it hard to stay on medication consistently. When that's the situation, a non-drug option that adds to their existing care can be genuinely valuable. That's the role TMS plays here: another tool for teens whose depression hasn't lifted enough with medication and therapy alone, not a first move and not a standalone fix.
Show More